MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6405-1085-1091$20.00
Mol Pharmacol 64:1085-1091, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, Q.
Right arrow Articles by Kozasa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, Q.
Right arrow Articles by Kozasa, T.

Interaction of G Protein {beta} Subunit with Inward Rectifier K+ Channel Kir3

Qi Zhao, Takeharu Kawano, Hiroko Nakata, Yasuko Nakajima, Shigehiro Nakajima, and Tohru Kozasa

Departments of Pharmacology (Q.Z., H.N, S.N., T.Ko.) and Anatomy and Cell Biology, College of Medicine, University of Illinois at Chicago, Illinois 60612 (T.Ka., Y.N.)

G protein {beta}{gamma} subunits bind and activate G protein-coupled inward rectifier K+ (GIRK) channels. This protein-protein interaction is crucial for slow hyperpolarizations of cardiac myocytes and neurons. The crystal structure of G{beta} shows a seven-bladed propeller with four {beta} strands in each blade. The G{beta}/G{alpha} interacting surface contains sites for activating GIRK channels. Furthermore, our recent investigation using chimeras between G{beta}1 and yeast {beta} (STE4) suggested that the outer strands of blades 1 and 2 of G{beta}1 could be an interaction area between G{beta}1 and GIRK. In this study, we made point mutations on suspected residues on these outer strands and investigated their ability to activate GIRK1/GIRK2 channels. Mutations at Thr-86, Thr-87, and Gly-131, all located on the loops between {beta}-strands, substantially reduced GIRK channel activation, suggesting that these residues are G{beta}/GIRK interaction sites. These mutations did not affect the expression of G{beta}1 or its ability to stimulate PLC{beta}2. These residues are surface-accessible and located outside G{beta}/G{alpha} interaction sites. These results suggest that the residues on the outer surface of blades 1 and 2 are involved in the interaction of G{beta}{gamma} with GIRK channels. Our study suggests a mechanism by which different effectors use different blades to achieve divergence of signaling. We also observed that substitution of alanine for Trp-332 of G{beta}1 impaired the functional interaction of G{beta}1 with GIRK, in agreement with the data on native neuronal GIRK channels. Trp-332 plays a critical role in the interaction of G{beta}1 with G{alpha} as well as all effectors so far tested.


Received May 12, 2003; accepted August 8, 2003

Address correspondence to: Tohru Kozasa, Department of Pharmacology, College of Medicine, University of Illinois at Chicago, 835 S. Wolcott Ave., Chicago, IL 60612. E-mail: tkozas{at}uic.edu




This article has been cited by other articles:


Home page
J. Physiol.Home page
M. Koike-Tani, J. M Collins, T. Kawano, P. Zhao, Q. Zhao, T. Kozasa, S. Nakajima, and Y. Nakajima
Signal transduction pathway for the substance P-induced inhibition of rat Kir3 (GIRK) channel
J. Physiol., April 15, 2005; 564(2): 489 - 500.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Li, H. Zhong, T. Scheuer, and W. A. Catterall
Functional Role of a C-Terminal G{beta}{gamma}-Binding Domain of Cav2.2 Channels
Mol. Pharmacol., September 1, 2004; 66(3): 761 - 769.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics